WO2001057209A3 - Nouvelle famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications - Google Patents

Nouvelle famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications Download PDF

Info

Publication number
WO2001057209A3
WO2001057209A3 PCT/FR2001/000359 FR0100359W WO0157209A3 WO 2001057209 A3 WO2001057209 A3 WO 2001057209A3 FR 0100359 W FR0100359 W FR 0100359W WO 0157209 A3 WO0157209 A3 WO 0157209A3
Authority
WO
WIPO (PCT)
Prior art keywords
proteins
cancer
same
novel family
sequences coding
Prior art date
Application number
PCT/FR2001/000359
Other languages
English (en)
Other versions
WO2001057209A2 (fr
Inventor
Clara Nahmias
Arthur Donny Strosberg
Sandrine Nouet
Original Assignee
Centre Nat Rech Scient
Clara Nahmias
Arthur Donny Strosberg
Sandrine Nouet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Clara Nahmias, Arthur Donny Strosberg, Sandrine Nouet filed Critical Centre Nat Rech Scient
Priority to AU2001235623A priority Critical patent/AU2001235623A1/en
Priority to EP01907725A priority patent/EP1254225A2/fr
Publication of WO2001057209A2 publication Critical patent/WO2001057209A2/fr
Publication of WO2001057209A3 publication Critical patent/WO2001057209A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Nouvelle famille de protéines humaines (hATIP), interagis-sant avec le récepteur AT2 de l'angiotensine II et possédant une fonction d'anti-oncogène. Ladite famille de protéines est donc utile pour le diagnostic des états cancéreux et précancéreux et le traitement des états cancéreux. Gène codant pour lesdites protéines, fragments dudit gène et leurs applications pour la détection et l'expression desdites protéines. Anticorps dirigés contre lesdites protéines ainsi qu'à des procédés de détection et/ou de dépistage d'un état précancéreux ou cancéreux à l'aide desdites protéi nes desdits anticorps et/ou des différentes séquences d'acides nucléiques.
PCT/FR2001/000359 2000-02-07 2001-02-07 Nouvelle famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications WO2001057209A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001235623A AU2001235623A1 (en) 2000-02-07 2001-02-07 Novel family of proteins, called atip, nucleic sequences coding for same and uses thereof
EP01907725A EP1254225A2 (fr) 2000-02-07 2001-02-07 Nouvelle famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0001504A FR2804690B1 (fr) 2000-02-07 2000-02-07 Nouvelles famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications
FR00/01504 2000-02-07

Publications (2)

Publication Number Publication Date
WO2001057209A2 WO2001057209A2 (fr) 2001-08-09
WO2001057209A3 true WO2001057209A3 (fr) 2002-04-11

Family

ID=8846732

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/000359 WO2001057209A2 (fr) 2000-02-07 2001-02-07 Nouvelle famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications

Country Status (4)

Country Link
EP (1) EP1254225A2 (fr)
AU (1) AU2001235623A1 (fr)
FR (1) FR2804690B1 (fr)
WO (1) WO2001057209A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003010198A1 (fr) * 2001-07-26 2003-02-06 Kenton Srl Identification d'antigenes tumoraux specifiques par selection de bibliotheques d'adnc avec des serums et utilisation de ces antigenes dans des techniques de diagnostic
JP2014513062A (ja) 2011-03-10 2014-05-29 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 癌の処置における使用のためのａｔｉｐ３およびその生物学的に活性なフラグメント
WO2014089348A1 (fr) * 2012-12-07 2014-06-12 Synthetic Genomics, Inc. Séquences de tête épissées de nannochloropsis et leurs utilisations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008148A1 (fr) * 1998-08-04 2000-02-17 Centre National De La Recherche Scientifique - Cnrs Sequences nucleiques codant pour une proteine (atip) interagissant avec le recepteur at2 et leurs applications

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008148A1 (fr) * 1998-08-04 2000-02-17 Centre National De La Recherche Scientifique - Cnrs Sequences nucleiques codant pour une proteine (atip) interagissant avec le recepteur at2 et leurs applications

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL SEQUENCES 11 November 1999 (1999-11-11), OHARA O. ET AL.: "Homo sapiens mRNA for KIAA1288", XP002151354 *
DATABASE EMBL SEQUENCES 22 July 1999 (1999-07-22), HILLIER L.: "ar99c09.x1 Barstead colon HPLRB7 H. sapiens cDNA clone IMAGE:2173744.", XP002175496 *
DATABASE GENBANK SEQUENCES 21 May 1999 (1999-05-21), NAKAMURA Y.: "H. sapiens genomic DNA of 8p21.3-p22", XP002175498 *
DATABASE GENBANK SEQUENCES 21 May 1999 (1999-05-21), NAKAMURA Y: "H. sapiens genomic DNA of 8p21.3-p22", XP002175497 *
NAGASE T. ET AL.: "Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.", DNA RES., vol. 6, 1999, pages 337 - 345, XP002943288, DOI: doi:10.1093/dnares/6.5.337 *

Also Published As

Publication number Publication date
WO2001057209A2 (fr) 2001-08-09
AU2001235623A1 (en) 2001-08-14
FR2804690B1 (fr) 2004-11-05
FR2804690A1 (fr) 2001-08-10
EP1254225A2 (fr) 2002-11-06

Similar Documents

Publication Publication Date Title
PH12016502583A1 (en) A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
EP1097994A3 (fr) Polypeptides Bad humaine codant des acides nucléitiques et leurs procédés d'utilisation
WO2000009709A3 (fr) Proteases et proteines associees
WO2000050607A3 (fr) Proteine de liaison a l'antigene du syndrome de goodpasture
WO2000044900A3 (fr) Proteines liant des acides nucleiques
WO2001057209A3 (fr) Nouvelle famille de proteines, denommees atip, les sequences nucleiques codant pour lesdites proteines et leurs applications
WO2002034915A3 (fr) Segments preferes de la proteine neurale ntp et ses procedes d'utilisation
WO2000031263A3 (fr) Proteines associees a la gtpase
WO2002000719A3 (fr) Nouveaux recepteurs
WO1998051782A3 (fr) 3-hydroxyisobutyryl-coenzyme a hydrolase humaine
WO2001065262A3 (fr) Reactifs et methodes de detection des pathologies mammaires
WO2000023466A3 (fr) Proteines humaines de fixation de l'arn
WO2003004678A3 (fr) Nouveaux recepteurs
WO1998041538A3 (fr) Nouvelle proteine receptrice des cytokines/steroides humaine
WO2001059114A3 (fr) Nouveau gene suppresseur de tumeurs p47ing3
WO1999064584A3 (fr) Proteine pour la regulation de l'apoptose
WO2003014742A3 (fr) Identification d'auto-anticorps humains
WO2001051642A3 (fr) Proteines de modification d'adn
WO2003029482A3 (fr) Diagnostic, traitement et prevention du cancer grace a la proteine cables
WO2002017947A3 (fr) Utilisation de proteines t pour une caracterisation et une therapie differentielles de lesions et de tumeurs du systeme nerveux
AU2002210636A1 (en) Polymorphic sequences of the human ABCA1 gene, their uses, detection methods and kits
WO2002040649A8 (fr) Slo2 et slo4, nouvelles proteines de canal potassique provenant du cerveau humain
WO2000012046A3 (fr) Acides nucleiques et polypeptides pkdl; methodes diagnostiques et therapeutiques
WO2002050279A3 (fr) Proteines associees a un acide nucleique
WO2000008156A3 (fr) Proteines associees a la reparation et a la replication d'adn humain

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001907725

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001907725

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001907725

Country of ref document: EP